Ondem (Generic Ondansetron Hydrochloride Tablets) is a serotonin 5-HT3 receptor antagonist, which is used mainly as an anti-emetic (to treat nausea and vomiting), often following chemotherapy or radiotherapy. It is also used for prevention of postoperative nausea and/or vomiting.
Its effects are ...
Ondem (Generic Ondansetron Hydrochloride Tablets) is a serotonin 5-HT3 receptor antagonist, which is used mainly as an anti-emetic (to treat nausea and vomiting), often following chemotherapy or radiotherapy. It is also used for prevention of postoperative nausea and/or vomiting.
Its effects are thought to be on both peripheral and central nerves. Ondansetron reduces the activity of the vagus nerve, which deactivates the vomiting center in the medulla oblongata, and also blocks serotonin receptors in the chemoreceptor trigger zone.
Ondem tablets are manufactured by Alkem Laboratories Limited, India in the strengths of 4 mg and 8 mg.
You should only take Ondem exactly as directed by your doctor. The
dosage of Ondem tablets (Generic Ondansetron Hydrochloride tablets)
is given below:
Emetogenic Chemotherapy and Radiotherapy:The recommended oral dose
of is 8 mg one to two hours before treatment, followed by 8 mg orally 12
hours later. The recommended oral dose is 8 mg to be taken twice daily.
To protect against delayed or prolonged emesis after the first 24 hours,
oral treatment with Ondansetron should be continued for up to 5 days
after a course of treatment.
Post-Operative Nausea and Vomiting: For prevention of post-operative
nausea and vomiting, the recommended oral dose is 16 mg given one hour
prior to anaesthesia.
URL: https://www.clearskypharmacy.biz/generic-zofran-ondem-by-alkem.html
Ondem Tablets (Generic Ondansetron
Hydrochloride Tablets) have to be stored at
controlled room temperature i.e. from 20°C to
25°C (68°F to 77°F) with excursions
permitted between 15° to 30°C (59° to 86°F).
Keep this as well as all other medicines away
from children and pets.
URL: https://www.clearskypharmacy.biz/generic-zofran-ondem-by-alkem.html
Hypersensitivity reactions including anaphylaxis and bronchospasm: Ondem
must be discontinued in case in case Hypersensitivity reactions are suspected.
Monitor and treat immediately per standard of care until signs and symptoms
resolve.
QT interval prolongation and Torsade de Pointes: Avoid administration of this
medicine in patients with congenital long QT syndrome; monitor with
electrocardiograms (ECGs) if concomitant electrolyte abnormalities, cardiac
failure or arrhythmias, or use of other QT prolonging drugs.
Serotonin syndrome: Reported with 5-HT3 receptor antagonists alone but
particularly with concomitant use of serotonergic drugs. In case such
symptoms occur, stop Ondem tablets and start supportive treatment. In case
concomitant use of Ondem with other serotonergic drugs is clinically
warranted, patients should be made aware of a potential increased risk for
serotonin syndrome.
Masking of progressive ileus and/or gastric distention following
abdominal surgery or chemotherapy-induced nausea and vomiting:
Monitor for decreased bowel activity, particularly in patients with risk
factors for gastrointestinal obstruction.
Phenylketonuria: Patients should be informed that Ondem MD orally
disintegrating tablets contain phenylalanine (a component of
aspartame). Each 4 mg and 8 mg orally disintegrating tablet contains
less than 0.03 mg phenylalanine.
Based on reports of profound hypotension and loss of consciousness
when Apomorphine was administered with Ondansetron, concomitant
use of Apomorphine with ondansetron is contraindicated.